| NCT Number | NCT07377591 |
| Lead Sponsor | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
| Conditions | Advanced Solid Tumors |
| Enrollment | 48 participants |
| Start Date | 2024-12-31 |
| Primary Completion | 2026-09 (estimated) |
| Study Completion | 2027-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-30 |